|
ABBV's Free Cash Flow Growth by Quarter and Year
Abbvie Inc 's Free Cash Flow results by quarter and year
Select the Comparisons :
|
|
Select the Ratio:
|
Free Cash Flow Growth Y/Y▼
|
Free Cash Flow Growth Y/Y▼
|
ABBV Free Cash Flow (in millions $) |
FY 2023 |
FY 2022 |
FY 2021 |
FY 2020 |
IV Quarter |
December |
4,753.00
|
7,428.00
|
5,075.00
|
4,854.00
|
III Quarter |
September |
7,574.00
|
7,602.00
|
7,935.00
|
5,830.00
|
II Quarter |
June |
6,319.00
|
5,005.00
|
4,890.00
|
3,089.00
|
I Quarter |
March |
4,193.00
|
4,908.00
|
4,877.00
|
3,815.00
|
FY |
|
22,839.00
|
24,943.00
|
22,777.00
|
17,588.00
|
ABBV Free Cash Flow fourth quarter 2023 Y/Y Growth Comment |
Abbvie Inc reported fall in Free Cash Flow in the fourth quarter 2023 by -36.01% to $ 4,753.00 millions, from the same quarter in 2022. The drop in the fourth quarter 2023 Abbvie Inc 's Free Cash Flow compares unfavorably to the Company's average Free Cash Flow increase of 16.27%.
Looking into fourth quarter 2023 results within Major Pharmaceutical Preparations industry 22 other companies have achieved higher Free Cash Flow growth. While Abbvie Inc ' s Free Cash Flow drop of -36.01% ranks overall at the positon no. 1102 in the fourth quarter 2023.
|
ABBV Free Cash Flow ( Y/Y Growth %) |
2023
|
2022 |
2021 |
2020 |
IV Quarter |
December |
-36.01 % |
46.36 % |
4.55 % |
48.21 % |
III Quarter |
September |
-0.37 % |
-4.2 % |
36.11 % |
27.99 % |
II Quarter |
June |
26.25 % |
2.35 % |
58.3 % |
24.71 % |
I Quarter |
March |
-14.57 % |
0.64 % |
27.84 % |
26.45 % |
FY |
|
-8.44 % |
9.51 % |
29.5 % |
32 % |
ABBV Free Cash Flow (Quarter on Quarter Growth %) |
2023
|
2022 |
2021 |
2020 |
IV Quarter |
December |
-37.25 % |
-2.29 % |
-36.04 % |
-16.74 % |
III Quarter |
September |
19.86 % |
51.89 % |
62.27 % |
88.73 % |
II Quarter |
June |
50.7 % |
1.98 % |
0.27 % |
-19.03 % |
I Quarter |
March |
-43.55 % |
-3.29 % |
0.47 % |
16.49 % |
FY (Year on Year) |
|
-8.44 % |
9.51 % |
29.5 % |
32 % |
Free Cash Flow Y/Y Growth Statistics |
High |
Average |
Low |
222.85 % |
16.27 % |
-85.06 % |
(Sep 30 2015) |
|
(Dec. 31. 2012) |
|
Free Cash Flow Y/Y Growth Statistics |
High |
Average |
Low |
222.85 % |
16.27 % |
-85.06 % |
(Sep 30 2015) |
|
(Dec. 31. 2012) |
|
Free Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023 |
Abbvie Inc 's Q/Q Free Cash Flow Growth
Free Cash Flow Q/Q Growth Statistics |
High |
Average |
Low |
223.41 % |
19.21 % |
-80.85 % |
(June 30. 2014) |
|
|
ABBV's IV. Quarter Q/Q Free Cash Flow Comment |
In the IV. Quarter 2023 Abbvie Inc realized fall in Free Cash Flow sequentially by -37.25% to $ 4,753.00 millions, from $ 7,574.00 millions declared a quarter before.
This is not huge problem, as IV. Quarter Free Cash Flow always tend to slow in the IV. Quarter Austin Lee, Major Pharmaceutical Preparations industry veteran located in New York wrote.
Within Major Pharmaceutical Preparations industry 16 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Abbvie Inc 's Free Cash Flow growth quarter on quarter, overall rank is 882. |
|
|
Free Cash Flow Q/Q Growth Statistics |
High |
Average |
Low |
223.41 % |
19.21 % |
-80.85 % |
(June 30. 2014) |
|
|
ABBV's IV. Quarter Q/Q Free Cash Flow Comment |
In the IV. Quarter 2023 Abbvie Inc reported fall in Free Cash Flow from the previous quarter by -37.25% to $ 4,753.00 millions, from $ 7,574.00 millions declared in the previous quarter.
As we evaluate current slump at the IV. Quarter, we suppose to presume, that usually IV. Quarter Free Cash Flow emerge sluggish in contrast to the quarter before, Austin Lee, Major Pharmaceutical Preparations industry veteran located in New York added.
Within Major Pharmaceutical Preparations industry 16 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Abbvie Inc 's Free Cash Flow growth quarter on quarter, overall rank is 882. |
|
Abbvie Inc 's 12 Months Free Cash Flow Growth Year on Year
Free Cash Flow TTM Growth |
12 Months Ending (Dec 31 2023) |
12 Months Ending (Sep 30 2023) |
12 Months Ending (Jun 30 2023) |
12 Months Ending (Mar 31 2023) |
12 Months Ending (Dec 31 2022) |
Cumulative Free Cash Flow 12 Months Ending |
$ 23,616.00 |
$ 26,299.00 |
$ 26,285.00 |
$ 24,936.00 |
$ 25,638.00 |
Y / Y Free Cash Flow Growth (TTM) |
-7.89 % |
13.07 % |
11.23 % |
5.8 % |
8.8 % |
Year on Year Free Cash Flow Growth Overall
Ranking |
# 680 |
# 1452 |
# 712 |
# 715 |
# 550 |
Seqeuential Free Cash Flow Change (TTM) |
-10.2 % |
0.05 % |
5.41 % |
-2.74 % |
10.23 % |
Seq. Free Cash Flow Growth (TTM) Overall
Ranking |
# 664 |
# 1465 |
# 1371 |
# 1049 |
# 946 |
Cumulative Free Cash Flow growth
Comment |
For the 12 months ended Dec 31 2023 Abbvie Inc reported a decrease in Free Cash Flow by -7.89% year on year, to $23,616 millions, compare to the 13.07% growth at Sep 30 2023.
In the Healthcare sector 48 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Total ranking has impoved so far to 680, from total ranking in previous quarter at 1452. |
Free Cash Flow TTM Q/Q Growth Statistics |
High |
Average |
Low |
93.87 % |
7.41 % |
-62.2 % |
|
|
|
|
|
Free Cash Flow TTM Y/Y Growth Statistics |
High |
Average |
Low |
93.87 % |
7.41 % |
-62.2 % |
|
|
|
Free Cash Flow TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 9 |
Sector |
# 48 |
S&P 500 |
# 664 |
|
Cumulative Free Cash Flow growth
Comment |
For the 12 months ended Dec 31 2023 Abbvie Inc reported a decrease in Free Cash Flow by -7.89% year on year, to $23,616 millions, compare to the 13.07% growth at Sep 30 2023.
In the Healthcare sector 48 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Total ranking has impoved so far to 680, from total ranking in previous quarter at 1452. |
Free Cash Flow TTM Q/Q Growth Statistics |
High |
Average |
Low |
93.87 % |
7.41 % |
-62.2 % |
|
|
|
Free Cash Flow TTM Y/Y Growth Statistics |
High |
Average |
Low |
93.87 % |
7.41 % |
-62.2 % |
|
|
|
Free Cash Flow TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 9 |
Sector |
# 48 |
S&P 500 |
# 664 |
|